Over the Counter CBD Products Help Dispel Outdated Stigmas
FinancialBuzz.com News Commentary
Share this article
Share this article
NEW YORK, March 16, 2021 /PRNewswire/ -- Due to recent regulatory changes, the cannabis industry is slowly evolving out of the black market and morphing into a global economic powerhouse. As such, the CBD market is much more attractive in the U.S. because of the passage of the Farm Bill in late 2018. The bill legalized hemp-derived CBD products as long as they contained 0.3% THC or less. Consequently, CBD products began to rapidly emerge in retailers across the country. Even though both hemp and marijuana belong to the cannabis family, the major difference between the two is that CBD does not stimulate psychotropic effects, while THC does indeed cause mind-altering effects. Now, as a result of this understanding, more countries have become keen to approve CBD as a medical treatment solution. HempFusion Wellness Inc. (TSX: CBD.U) (OTC: CBDHF), Tilray, Inc. (NASDAQ: TLRY), Aurora Cannabis Inc. (NYSE: ACB), Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), Trulieve Cannabis Corp. (OTC: TCNNF) (CSE: TRUL)